Amgen sues state over price cap law
Drug maker Amgen, the maker of Enbrel, has sued the state because of the Prescription Drug Affordability Board decision to cap the price of the drug.
The Denver Post reported that the drug maker believes that the law permitting the price cap is unconstitutional and conflicts with federal law.
SPONSORED CONTENT
Federal District Court Rules Corporate Transparency Act Unconstitutional . . . But Most Small Businesses Must Still Comply
Lyons Gaddis Real Estate and Business Attorney Cameron Grant shares important details of the Corporate Transparency Act (CTA).